Cash Flow Statement

Asset Writedowns and Impairment Beginning Cash Balance Change in Receivables Change in Working Capital Deferred Taxes Net Debt Issuances and Repayments Other Working Capital Changes Other financing activities

Daily Values

Growth Metrics

Income Statement

Others

Ratios

Zhengye Biotechnology Holding (ZYBT) Asset Writedowns and Impairment: 2022-2024

Historic Asset Writedowns and Impairment for Zhengye Biotechnology Holding (ZYBT) over the last 3 years, with Dec 2024 value amounting to $817,000.